Pulse nav.journalClub 트렌드 탐색 질문 연구자

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026개인정보 처리방침

홈 탐색 nav.journalClub 트렌드

⌘+K

Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry | Synapse

January 1, 1991Open Access

Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry

Key Points

Key points are not available for this paper at this time.

Abstract

microeconomics, pharmaceutical industry, health care, technology, patent protection

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Caves et al. (Tue,) studied this question.

synapsesocial.com/papers/6a20043977451c29e065ada9 https://doi.org/https://doi.org/10.2307/2534790

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The political economy of the pharmaceutical industry.1986 · 169 citations
2Taking Your Medicine: Drug Regulation in the United States1982 · 175 citations
3Technology, Regulation, and Market Structure in the Modern Pharmaceutical Industry1979 · 82 citations
4On the Accuracy of Producer Price Indexes for Pharmaceutical Preparations: An Audit Based on Detailed Firm-Specific Data1990 · 11 citations
5"Innovation in the Pharmaceutical Industry".1978 · 193 citations